Abstract-Exaggerated cardiovascular reactivity to behavioral challenges among otherwise healthy individuals has been associated with carotid atherosclerosis. We evaluated whether a similar relationship exists among hypertensives, who are at a heightened atherosclerotic risk. Untreated, hypertensive men (nϭ251; age range, 40 to 70 years; 197 white, 54 black) completed a standardized battery of behavioral challenges while their blood pressure responses to the battery were measured. Mean and maximum carotid intima-media thickness and the occurrence of carotid plaques were subsequently determined using B-mode ultrasonography. Although greater systolic and diastolic responses to the battery were associated with greater mean and maximum intima-media thickness in univariate analyses (PϽ0.01), only diastolic reactivity showed a unique association with mean and maximum carotid intima-media thickness after multivariate adjustment for age, race, socioeconomic status, smoking and alcohol use, body mass index, lipid profile, glucose and insulin concentrations, and resting blood pressure (PϽ0.05). Carotid plaque occurrence was associated with greater systolic reactivity (Pϭ0.05) and was marginally associated with greater diastolic reactivity (Pϭ0.07) in univariate analyses, but neither systolic nor diastolic reactivity was uniquely associated with the presence of carotid plaques after multivariate risk-factor adjustment. Among hypertensives, exaggerated behaviorally evoked cardiovascular reactivity appears to be uniquely associated with greater carotid intima-media thickness but not with carotid plaque occurrence. Key Words: atherosclerosis Ⅲ cardiovascular reactivity Ⅲ carotid intima-media thickness Ⅲ carotid plaque Ⅲ stress T wo lines of research indicate that exaggerated cardiovascular reactivity to behavioral challenges is associated with atherosclerosis. First, cynomolgus macaques that display exaggerated heart rate (HR) reactivity to the threat of capture also display the most pronounced carotid and coronary atherosclerosis on necropsy. 1,2 Second, humans who display exaggerated blood pressure reactivity to behavioral stressors are more likely to have increased carotid intima-media thickness (IMT), 3-7 higher carotid plaque occurrence, 3 greater carotid plaque height, 4 -6 and larger carotid plaque surface areas 7 compared with levels for individuals who display attenuated blood pressure reactivity. Together, these 2 lines of research are consistent with the hypothesis that a disposition to respond to behavioral challenges with exaggerated cardiovascular reactions may enhance the risk for atherosclerosis. 8 To our knowledge, however, no studies have examined whether exaggerated, behaviorally evoked cardiovascular reactivity is associated with atherosclerosis among individuals with hypertension, which is a leading risk factor for atherosclerosis. 9 -14 Indeed, the majority of research on cardiovascular reactivity and hypertension has focused on the extent to which exaggerated cardiovascular reactivity predicts the development of hypertension, 15-17 or on whether hypertensives or those at risk for hypertension differ from controls in cardiovascular or autonomic nervous system reactivity to behavioral stressors. 18, 19 Consequently, it is unclear whether the relationship between cardiovascular reactivity and atherosclerosis, which has been documented in otherwise healthy individuals, generalizes to hypertensives.
T wo lines of research indicate that exaggerated cardiovascular reactivity to behavioral challenges is associated with atherosclerosis. First, cynomolgus macaques that display exaggerated heart rate (HR) reactivity to the threat of capture also display the most pronounced carotid and coronary atherosclerosis on necropsy. 1, 2 Second, humans who display exaggerated blood pressure reactivity to behavioral stressors are more likely to have increased carotid intima-media thickness (IMT), [3] [4] [5] [6] [7] higher carotid plaque occurrence, 3 greater carotid plaque height, 4 -6 and larger carotid plaque surface areas 7 compared with levels for individuals who display attenuated blood pressure reactivity. Together, these 2 lines of research are consistent with the hypothesis that a disposition to respond to behavioral challenges with exaggerated cardiovascular reactions may enhance the risk for atherosclerosis. 8 To our knowledge, however, no studies have examined whether exaggerated, behaviorally evoked cardiovascular reactivity is associated with atherosclerosis among individuals with hypertension, which is a leading risk factor for atherosclerosis. 9 -14 Indeed, the majority of research on cardiovascular reactivity and hypertension has focused on the extent to which exaggerated cardiovascular reactivity predicts the development of hypertension, [15] [16] [17] or on whether hypertensives or those at risk for hypertension differ from controls in cardiovascular or autonomic nervous system reactivity to behavioral stressors. 18, 19 Consequently, it is unclear whether the relationship between cardiovascular reactivity and atherosclerosis, which has been documented in otherwise healthy individuals, generalizes to hypertensives.
The present study, therefore, examined (1) the crosssectional univariate relationships between HR and blood pressure reactivity to a standardized battery of behavioral challenges and indices of carotid atherosclerosis (mean and maximum carotid IMT and carotid plaque occurrence) in a sample of untreated hypertensives, and (2) whether HR and blood pressure reactivity are associated with these indices of carotid atherosclerosis after statistically controlling for age, race, socioeconomic status (SES), smoking status, alcohol use, body mass index (BMI), serum lipids, fasting glucose and insulin concentrations, and resting blood pressure.
Methods

Participants
Participants were 40-to 70-year-old men (nϭ251; 197 white, 54 black) enrolled in the University of Pittsburgh Reactivity and Cardiovascular Risk Trial (REACT), which was designed to study the relationship between carotid atherosclerosis and behaviorally evoked cardiovascular reactivity among untreated hypertensives. Participants were recruited via mass mailings to Allegheny County residents in Pennsylvania. Exclusion criteria included cardiovascular medication use in the 2-month period before enrollment; hypertension treatment Ͼ1 year in the 5-year period before enrollment or lifetime hypertension treatment exceeding 2 years (85% of the participants had no history of hypertension treatment; the median treatment length of the remaining participants was 2 months); secondary hypertension; cerebrovascular accident or stroke; insulin treatment for diabetes or diabetic neuropathy; fasting serum glucose Ͼ200 mg/dL; obesity; cancer; serum creatinine level Ͼ2 mg/dL; hepatitis or cirrhosis; coronary artery disease; myocardial infarction or angioplasty in the past 12 months; angina pectoris; congestive heart failure; valvular heart disease; atrial fibrillation; pulmonary disease; alcoholism; psychiatric disorder or current use of psychotropic medication; and coronary bypass, carotid, or peripheral vascular surgery. Participants provided informed consent, and the University of Pittsburgh's Institutional Review Board granted study approval.
Hypertension status was determined if the average of 2 seated resting blood pressure measurements fell between 140 and 180 mm Hg systolic blood pressure (SBP) and/or 90 and 110 mm Hg diastolic blood pressure (DBP) on each of 2 screening sessions.
Cardiovascular Reactivity Testing
Participants fasted and abstained from caffeinated beverages, tobacco products, and exercise for 3 hours before testing, and they refrained from drinking alcohol and taking nonessential medication for 12 hours before testing. A 20-minute rest period was initiated after participants were instrumented for physiological recording. After this period, participants completed a standardized reactivity battery 20 while SBP, DBP, and HR responses were measured. The battery was comprised of six 6-minute tasks delivered via a computer and included a speeded reaction-time task, a mirror-image tracing task, a guided-path target task, a Stroop color-word interference task, and an impromptu speech preparation and speech delivery task. A 9-minute baseline period 21 preceded each task.
Automated oscillometric measurements of SBP and DBP were obtained every 90 seconds using a Dinamap Vital Signs Monitor (Model 8100; Critikon), and HR was derived from a modified lead II ECG signal. 22 Reactivity estimates were standardized for each task by dividing the task-minus-baseline change score by the standard deviation of that change score. A single HR, SBP, and DBP reactivity estimate was then derived by averaging these standardized reactivity values across the tasks. 4 
Ultrasound Assessment of Carotid IMT and Carotid Plaque Occurrence
Mean and maximum carotid IMT and carotid plaque occurrence were derived using B-mode ultrasonography. Trained sonographers imaged the right and left common carotid artery, carotid bifurcation, and the first centimeter of the internal carotid artery with a Toshiba SSA-270 scanner that was equipped with a 5-Mhz linear-array imaging probe. Mean and maximum IMT were then derived from digitized images of the lumen-intima and media-adventitia interface across each carotid segment, and were averaged across the near and far walls of the right and left distal common carotid artery (1 cm proximal to the carotid bulb), the far wall of the carotid bulb (starting at the point at which the near and far walls of the common carotid artery are no longer parallel and ending at the flow divider), and the far wall of the internal carotid artery (from the flow divider to the first cm distal to this point). Plaques were defined as focal areas projecting in to the vessel lumen with a Ն50% thickness than the bordering areas, and plaque occurrence (coded as 0ϭnone and 1ϭՆ1) was determined for the proximal and distal common, bulb, internal, and external carotid segments.
In addition to the dichotomous measure of plaque occurrence, statistical analyses were also performed on a graded estimate of plaque severity, termed the plaque index. 23 For this estimate, plaque severity was coded in the following manner: 0ϭno plaque; 1ϭa single plaque that was Ͻ30% of the vessel diameter, 2ϭa single plaque that was between 30% to 50% of the vessel diameter or multiple plaques that were Ͻ30% of the vessel diameter, and 3ϭa plaque that was Ͼ50% of the vessel diameter or multiple plaques with one that was between 30% to 50% of the vessel diameter. To derive the plaque index, these scores from the right and left carotid arteries were summed. Because the results of the statistical analyses using the plaque index as a dependent measure did not differ from those using the more basic, dichotomous measure of 0ϭno plaques and 1ϭՆone plaques, they are omitted.
Cardiovascular Risk Factor Assessment
The following cardiovascular risk factors were assessed: BMI, smoking status (coded as current smoker versus nonsmoker), frequency of alcohol use, total family income before taxes, the number of completed school years, race (coded as 1ϭwhite; 2ϭblack), and SES, which was estimated by standardizing the number of years in school and average annual income and then taking the average of these 2 standardized values. Fasting levels of triglycerides, HDL and LDL, insulin, and glucose were also obtained (see Muldoon et al 24 for details regarding blood assays).
Data Analysis
Relationships between carotid IMT and cardiovascular reactivity were evaluated using 2-level hierarchical regression analyses in which independent variables were entered in the following order: level 1 was age, race, SES, smoking status, alcohol use, BMI, HDL, LDL, natural-log triglyceride values, glucose, insulin, and screening and baseline values of the target cardiovascular parameter; level 2 was the cardiovascular reactivity estimate (HR, SBP, or DBP reactivity). We evaluated the proportion of variance in carotid IMT accounted for by the set of covariates in level 1 (R 2 ), and the increment in the proportion of variance accounted for by the reactivity estimate in Level 2 (⌬R 2 ). Unique correlations between each independent variable and IMT measure were evaluated using the partial correlation coefficient (r p ). Associations between plaque occurrence and cardiovascular risk factors were evaluated using logistic regression analyses from which we evaluated odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for each independent variable in the model. Table 1 contains descriptive characteristics of the sample, along with univariate correlations between atherosclerosis risk factors and carotid IMT and carotid plaque occurrence. Mean plasma lipid levels, glucose, insulin, and BMI were all within normal ranges. There were relatively few current smokers (13%) in the present sample, and the majority of individuals (72%) reported consuming Յ2 alcoholic beverages per week. The average number of years that the participants reported attending school was 14.8Ϯ2.8 years. The percentages of participants reporting total family incomes before taxes were as follows: 6.1% earning Ͼ$10 000, 12.6% earning between $10 000 and $19 999, 20.2% earning between $20 000 and $34 999, 19.8% earning between $35 000 and $50 000, and 41.3% reported earning Ͼ$50 000. Average SBP, DBP, and HR reactivity were comparatively higher than those reported in other studies using the same laboratory challenges. 20 Consistent with previous findings, average mean (0.92 mm) and maximum (1.20 mm) carotid IMT levels were moderately elevated in this hypertensive sample; in addition, 69% of the present sample had Ն1 focal carotid plaques.
Results
Descriptive Characteristics
Univariate Associations Between Cardiovascular Risk Factors and Carotid Atherosclerosis
Univariate correlation analyses showed that greater mean and maximum carotid IMT were associated with advanced age, lower SES, higher LDL and glucose concentrations, increased screening and baseline SBP, and lower screening and baseline DBP (all, PϽ0.01; Table 1 ). In addition, greater SBP and DBP, but not HR, reactivity to the test battery were associated with greater mean and maximum IMT (PϽ0.01; Table 1 ).
As shown in Table 1 , the presence of carotid plaque was associated with increased age, higher LDL, higher screening SBP, lower screening and baseline DBP, greater mean and maximum carotid IMT, and greater SBP reactivity (PϽ0.05). Having Ն1 carotid plaques was also marginally associated with greater DBP reactivity (Pϭ0.067). None of the remaining variables showed a univariate association with carotid plaque occurrence.
Unique Associations Between Behaviorally Evoked Cardiovascular Reactivity and Carotid Atherosclerosis
Across all hierarchical regression analyses for each cardiovascular reactivity parameter, age, SES, LDL, and screening blood pressure accounted for a unique percentage of the variance in mean and maximum IMT after adjusting for other variables in the model (PϽ0.05; Table 2 for results from DBP regression analyses). In contrast with the univariate results, however, glucose and baseline SBP and DBP at the time of reactivity testing did not show statistically independent relationships with carotid IMT after covariate adjustment.
In addition, DBP reactivity to the battery showed a unique and positive association with mean and maximum carotid IMT after covariate adjustment. The Analyses of carotid plaque occurrence were also conducted using regression models that covaried only those variables showing a significant univariate correlation with carotid plaque (age, LDL, screening SBP and DBP, and baseline SBP and DBP; Table 1 ). The results of these reduced-model analyses, however, yielded the same findings as those from the full-covariate models: no measure of cardiovascular reactivity was associated with carotid plaque after covariate adjustment.
Discussion
In this cross-sectional study, we evaluated whether greater behaviorally evoked cardiovascular reactivity is related to ultrasound measures of carotid atherosclerosis among hypertensive men. Participants in the present study were untreated for hypertension at the time of study (85% had never received treatment, and the remaining participants had a median lifetime treatment length of 2 months), which controlled for the possible confounding effects of antihypertensive treatment on cardiovascular reactivity and other study variables.
Overall, we found that greater blood pressure reactivity to a standardized battery of behavioral challenges was related to increased mean and maximum carotid IMT in univariate analyses; however, only exaggerated DBP reactivity was associated uniquely with increased mean and maximum carotid IMT after multivariate risk-factor adjustment. This association between exaggerated DBP reactivity and increased carotid IMT accords with recent reports [3] [4] [5] [6] [7] that indicated that greater behaviorally evoked cardiovascular reactivity is similarly associated with increased carotid IMT among individuals without hypertension. Differing from the carotid IMT findings, however, were those regarding carotid plaque occurrence. Specifically, although greater SBP reactivity was associated significantly, and DBP reactivity marginally, with having Ն1 carotid plaques in univariate analyses, neither of these 2 estimates of cardiovascular reactivity Adjusted mean and maximum carotid IMT as a function of DBP reactivity to a standardized battery of behavioral challenges. IMT measures were adjusted for age, race, SES, smoking and alcohol use, BMI, HDL, LDL, triglycerides, glucose, insulin, screening DBP, and resting DBP at the time of reactivity testing.
was related to the presence of carotid plaques after adjusting for other cardiovascular risk factors. These particular findings contrast with those of prior studies that indicated that behaviorally evoked cardiovascular reactivity is associated positively with measures of carotid plaque among individuals without hypertension. 3, 4, 7 Finally, HR reactivity was not related to any measure of carotid atherosclerosis in this hypertensive sample, which replicates findings from prior studies among normotensive individuals. 3, 4, 7 An individual's tendency to show exaggerated cardiovascular reactivity to behavioral challenges has been hypothesized 8 to increase the risk of developing atherosclerosis by at least 2 possible mechanisms: exaggerated or sustained cardiovascular responses may promote atherosclerosis by sympathetically mediated lipid mobilization and platelet aggregation 25 or by pressor-induced blood flow disruptions that lead to endothelial injury. 26 -28 To the extent that measures of carotid IMT reflect levels of preclinical atherosclerosis, 29 -32 then the current results indicate that exaggerated behaviorally evoked DBP reactivity does account for a unique percentage of the variance in preclinical carotid atherosclerosis among untreated hypertensives. Furthermore, although DBP reactivity accounted for a relatively modest percentage of unique variance in carotid IMT indices after risk-factor adjustment (Ϸ1%), this percentage was comparable to what has been reported previously in nonhypertensive samples 4 -7 and was also comparable to or greater than the variance in carotid IMT that was accounted for by other recognized cardiovascular risk factors (eg, SES, smoking and alcohol use, BMI, glucose, and insulin; Table 2 ). The magnitude of the univariate and multivariate relationships between reactivity estimates and carotid ultrasound measures, however, was appreciably lower than that associated with age and LDL levels, both of which showed the strongest and most consistent relationships with carotid IMT and plaque occurrence.
Mean and maximum carotid IMT are widely accepted as valid markers of preclinical atherosclerosis because they correlate strongly with established risk factors for atherosclerosis, 29 are reduced with treatment for atherosclerosis, 30 are moderately correlated with indices of atherosclerosis in other vascular regions, 31, 32 and predict cardiac mortality and morbidity. [33] [34] [35] Criticisms, however, of mean and maximum carotid IMT as exclusive markers of atherosclerosis have been voiced. 36 In addition, at least 1 limitation of carotid IMT use in this study bears direct relevance to the interpretation of the present findings; namely, carotid IMT may reflect medial hypertrophy among hypertensives. 37 Given that B-Mode ultrasound measures do not distinguish between processes reflecting medial hypertrophy or intimal atherosclerosis, it is not possible to determine whether increased carotid IMT reflects preclinical atherosclerosis, adaptive medial thickening, or a combination of both processes among hypertensives. Thus, in the context of the present results, inferences regarding the relationship between exaggerated cardiovascular reactivity and carotid atherosclerosis (as reflected by increased carotid IMT) are necessarily limited. In addition, the lack of a statistically significant, unique association between measures of cardiovascular reactivity and carotid plaque occurrence in the present study casts further uncertainty on the interpretation of the findings for carotid IMT.
More specifically, if the presence of carotid plaque reflects a more clearly interpretable atherosclerotic endpoint compared with increased mean or maximum carotid IMT, then the correlation between exaggerated DBP reactivity and increased carotid IMT may represent a relationship that reflects atherosclerotic processes, hypertensive vascular remodeling, or possibly both. Moreover, although greater DBP reactivity was uniquely associated with increased mean and maximum carotid IMT, the present cross-sectional data do not exclude the possibility that processes related to increased carotid IMT (eg, vascular remodeling) may increase blood pressure reactivity. 8 Thus, future prospective studies should determine the temporal relationship between variations in behaviorally evoked cardiovascular reactivity and carotid IMT among hypertensives.
Perspectives
This is the first study, to our knowledge, to evaluate the relationship between behaviorally evoked cardiovascular reactivity and indices of carotid atherosclerosis among untreated hypertensives. Although increased DBP reactivity to a battery of behavioral challenges was associated with increased mean and maximum carotid IMT after statistically controlling for other cardiovascular risk factors, this finding may not necessarily indicate that cardiovascular reactivity is associated with carotid atherosclerosis among hypertensives. Indeed, the greater carotid IMT that was accounted for by enhanced blood pressure reactivity may have reflected processes that are related to an altered vascular morphology (eg, medial hypertrophy) among our hypertensive sample rather than carotid atherosclerosis per se. Further, behaviorally evoked cardiovascular reactivity was not uniquely associated with a more specific atherosclerotic endpoint, carotid plaque occurrence. These results may suggest that behaviorally evoked cardiovascular reactivity is not likely to be a primary determinant of carotid atherosclerosis among hypertensives. On the other hand, however, our sampling strategy may have affected the strength of the statistical association between carotid atherosclerosis and behaviorally evoked cardiovascular reactivity. Specifically, the self-selected nature of our study participants and our eligibility criteria may have yielded a sample of hypertensives that was relatively healthier (as reflected by low smoking and alcohol consumption rates, a relatively high SES, and normal ranges of glucose and cholesterol levels) than are the hypertensive samples that are typically studied. Thus, it is possible that a stronger relationship between carotid atherosclerosis and behaviorally evoked cardiovascular reactivity could exist in a more representative sample of hypertensive individuals.
